Luspatercept transforming the management of β-thalassaemia
28 Dec 2024
β-thalassaemia, an inherited haemoglobin disorder, affects approximately 1.5 percent of the global population, with 60,000 symptomatic individuals born annually, predominantly in low- and middle-income countries. [Orphanet J Rare Dis 2010;5:11]
Resources
Luspatercept transforming the management of β-thalassaemia
Luspatercept transforming the management of β-thalassaemia